Description
Research Areas
- Advanced dual amylin/GLP-1 combination research
- Body weight and fat mass reduction models
- Glycemic regulation across multiple pathways
$259.00
Higher-dose combination of Cagrilintide and Semaglutide for advanced dual-pathway metabolic research. Mirrors the CagriSema clinical formulation under study.
-
Phorm Labs
Additional information
| Please Select | 10 mg |
|---|
Reviews
There are no reviews yet.